Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4756 AL 4770

A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?

Luo JJ, Wallace W, Kusiak JW.

J Neurol Sci. 2022 Jul 15;438:120294. doi: 10.1016/j.jns.2022.120294. Epub 2022 May 23.

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

Sang Z, Wang K, Dong J, Tang L.

Eur J Med Chem. 2022 Aug 5;238:114464. doi: 10.1016/j.ejmech.2022.114464. Epub 2022 May 20.

Shared pathophysiology: Understanding stroke and Alzheimer's disease

Sriram S, Mehkri Y, Quintin S, Lucke-Wold B.

Clin Neurol Neurosurg. 2022 Jul;218:107306. doi: 10.1016/j.clineuro.2022.107306. Epub 2022 May 25.

Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease

Olloquequi J, Ettcheto M, Cano A, Sanchez-López E, Carrasco M, Espinosa T, Beas-Zarate C, Gudiño-Cabrera G, Ureña-Guerrero ME, Verdaguer E, Folch J, Auladell C, Camins A.

Front Biosci (Landmark Ed). 2022 May 6;27(5):146. doi: 10.31083/j.fbl2705146.

Abdominal fullness and discomfort induced by an extract of the Japanese herbal medicine Tsumura Ninjin'yoeito: The cases of two patients with Alzheimer's disease and anorexia

Sato S, Tamura M, Ide M, Matsuzaki A, Shiratori Y, Hisanaga A.

Psychiatry Clin Neurosci. 2022 Aug;76(8):406-407. doi: 10.1111/pcn.13431. Epub 2022 Jun 23.

Genetics of Alzheimer's disease: an East Asian perspective

Miyashita A, Kikuchi M, Hara N, Ikeuchi T.

J Hum Genet. 2023 Mar;68(3):115-124. doi: 10.1038/s10038-022-01050-z. Epub 2022 Jun 1.

A comprehensive review on the prevention and regulation of Alzheimer's disease by tea and its active ingredients

Huang Y, Wei Y, Xu J, Wei X.

Crit Rev Food Sci Nutr. 2023;63(30):10560-10584. doi: 10.1080/10408398.2022.2081128. Epub 2022 Jun 1.

Neglected N-Truncated Amyloid-β Peptide and Its Mixed Cu-Zn Complexes

Frączyk T, Cieplak P.

Protein J. 2022 Jun;41(3):361-368. doi: 10.1007/s10930-022-10056-7. Epub 2022 Jun 1.

Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients

Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C.

Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1.

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders

Tiepolt S, Meyer PM, Patt M, Deuther-Conrad W, Hesse S, Barthel H, Sabri O.

J Nucl Med. 2022 Jun;63(Suppl 1):33S-44S. doi: 10.2967/jnumed.121.263198.

The Potential of Genetic Data for Prioritizing Drug Repurposing Efforts

Gill D, Vujkovic M.

Neurology. 2022 Aug 16;99(7):267-268. doi: 10.1212/WNL.0000000000200803. Epub 2022 Jun 2.

The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer's disease and related neurological disorders

Mockett BG, Ryan MM.

Semin Cell Dev Biol. 2023 Apr;139:93-101. doi: 10.1016/j.semcdb.2022.05.014. Epub 2022 May 30.

Integrative analysis of summary data from GWAS and eQTL studies implicates genes differentially expressed in Alzheimer's disease

Lee B, Yao X, Shen L; Alzheimer’s Disease Neuroimaging Initiative.

BMC Genomics. 2022 Jun 2;23(Suppl 4):414. doi: 10.1186/s12864-022-08584-8.

Defective mitophagy and the etiopathogenesis of Alzheimer's disease

Zeng K, Yu X, Mahaman YAR, Wang JZ, Liu R, Li Y, Wang X.

Transl Neurodegener. 2022 Jun 3;11(1):32. doi: 10.1186/s40035-022-00305-1.

Recent Update on the Alzheimer's Disease Progression, Diagnosis and Treatment Approaches

Malaiya A, Singhai M, Singh M, Prajapati SK, Choudhury H, Fatima M, Alexander A, Dubey SK, Greish K, Kesharwani P.

Curr Drug Targets. 2022;23(10):978-1001. doi: 10.2174/1389450123666220526155144.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias